• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

AABB Issues Updated TRALI Risk Reduction Standards

August 23, 2013

The AABB has issued updated standards for blood banks and transfusion servicesto reduce the risk of transfusion-related acute lung injury (TRALI). The 29th edition of Standards for Blood Banks and Transfusion Services were approved by the AABB Board of Directors in July 2013. This edition includes new requirements for evaluating the eligibility of donors implicated in TRALI events and updated specifications for donors of high plasma volume components used in allogeneic transfusion. Specifically, “high plasma volume components for allogeneic transfusion (i.e. plasma, high plasma volume platelet components, and whole blood) shall be from males, females who have not been pregnant, or females who have been tested since their most recent pregnancy and results interpreted as negative for HLA antibodies.” The new standards will go into effect on April 1, 2014.

 

 

Reference

1.    AABB. TRALI Risk Reduction Requirements in the 29th Edition of BBTS Standards. Accessed onilne August 21, 2013.  2013. http://www.aabb.org/sa/standards/Pages/trali-requirements-bbts-standards.aspx.

Filed Under

  • Adverse Events (non-infectious)
  • News
  • Policy and Guidelines
  • Quality Control and Regulatory

Recommended

  • Immune Plasma: A Promising Therapy to Treat Influenza

  • Alloimmunization to One RBC Antigen Triggers Alloimmunization to Other RBC Antigens

  • Fresh Red Blood Cell Transfusions Do Not Improve Outcomes in Critically Ill Patients

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Mitochondrial DNA Acts as a “First Hit” for Antibody-Mediated TRALI

  • Liberal or Restrictive Transfusion Thresholds for Surgery Patients with High Cardiac Risk

  • Iron Supplementation for Blood Donors Based on Ferritin Levels

  • Impact of Individual Donor Assessment Deferral Changes on Donor HIV, HBV, HCV, and Syphilis Prevalence

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley